Evidence map›Paper›PMID 41685578›Full record

ArticleJournal of chemical information and modeling2026

Doing More with Less: Accurate and Scalable Ligand Free Energy Calculations by Focusing on the Binding Site.

David Alencar Araripe, Alejandro Díaz-Holguín, Antti Poso, Gerard J P van Westen, Johan Åqvist, Hugo Gutiérrez-de-Terán, Willem Jespers

Abstract read
In one paragraph

Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David Alencar AraripeDepartment of Medicinal Chemistry, Photopharmacology and Imaging, Groningen Research Institute of Pharmacy (GRIP), Faculty of Science and Engineering, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.ORCID 0000-0002-5104-1959
Alejandro Díaz-HolguínDepartment of Cell & Molecular Biology, Uppsala University, Biomedical Center, SE-75124 Uppsala, Sweden.
Antti PosoSchool of Pharmacy, University of Eastern Finland, P.O. Box 1627, 70211 Kuopio, Finland.ORCID 0000-0003-4196-4204
Gerard J P van WestenDivision of Medicinal Chemistry, Leiden Academic Centre for Drug Research, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands.ORCID 0000-0003-0717-1817
Johan ÅqvistDepartment of Cell & Molecular Biology, Uppsala University, Biomedical Center, SE-75124 Uppsala, Sweden.ORCID 0000-0003-2091-0610
Hugo Gutiérrez-de-TeránDepartment of Cell & Molecular Biology, Uppsala University, Biomedical Center, SE-75124 Uppsala, Sweden.ORCID 0000-0003-0459-3491
Willem JespersDepartment of Medicinal Chemistry, Photopharmacology and Imaging, Groningen Research Institute of Pharmacy (GRIP), Faculty of Science and Engineering, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.ORCID 0000-0002-4951-9220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting how chemical modifications affect drug binding is central to rational drug design. Free energy perturbation (FEP) calculations provide accurate estimates of these binding affinity changes, but existing methods often require substantial computational resources and expert knowledge. Here, we present QligFEP v2.1.0, a flexible open-source workflow based on a graphical and command-line interface for calculating relative binding free energies using spherical boundary conditions, which dramatically reduces simulation system size by confining simulations to a focused region around the binding site. QligFEP features a configurable restraint algorithm that automatically handles diverse chemical transformations, streamlined setup procedures, and enhanced analysis tools. We validated the method using industry benchmarks comprising 16 protein targets and 639 ligand transformations. Statistical analysis demonstrates that QligFEP achieves comparable accuracy to established commercial and open-source alternatives while requiring only a fraction of the computational resources. The perturbation protocol simulates ∼6250 atoms per perturbation leg and completes transformation replicates in under 2 h on standard computational clusters. Unlike full-system simulations, QligFEP's modest computational requirements make FEP accessible for less than $1 on current AWS spot instances. The combination of accuracy, flexibility, and computational efficiency positions QligFEP as a practical solution for accelerating compound optimization in drug discovery, making rigorous binding affinity predictions accessible for large scale applications and to research groups with limited computational infrastructure.

Indexed as

ProteinsAlgorithmsBinding SitesDrug DesignLigandsProtein BindingThermodynamicsLigandsProteins

Identifiers

PMID41685578
PMCPMC13014454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.